Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century

Background Male breast cancer (MBC) is a rare disease for which there is limited understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I to stage III breast cancer diagnosed between 2004 and 2014 in the National Cancer Data Base were included. Trends in treatment mod...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2020-01, Vol.126 (1), p.26-36
Main Authors: Yadav, Siddhartha, Karam, Dhauna, Bin Riaz, Irbaz, Xie, Hao, Durani, Urshila, Duma, Narjust, Giridhar, Karthik V., Hieken, Tina J., Boughey, Judy C., Mutter, Robert W., Hawse, John R., Jimenez, Rafael E., Couch, Fergus J., Leon‐Ferre, Roberto A., Ruddy, Kathryn J.
Format: Article
Language:English
Subjects:
Aged
Breast - pathology
Breast - surgery
Breast cancer
Breast Neoplasms, Male - epidemiology
Breast Neoplasms, Male - genetics
Breast Neoplasms, Male - surgery
Breast Neoplasms, Male - therapy
Cancer therapies
Chemotherapy
Clinical trials
Disease control
Endocrine therapy
Epidermal growth factor
Erb-b2 Receptor Tyrosine Kinases - genetics
ErbB-2 protein
Estrogen Receptor alpha - genetics
Estrogens
Gene Expression Regulation, Neoplastic - genetics
Growth factors
Humans
Kaplan-Meier Estimate
Lymph nodes
Male
male breast cancer
Mastectomy
Mastectomy, Segmental
Medical prognosis
Medical treatment
Mens health
Middle Aged
Multivariate analysis
Neoplasm Staging
Oncology
Patients
pattern
Progesterone
Prognosis
Radiation therapy
Rare diseases
Regression analysis
Regression models
Subgroups
Surgery
Survival
treatment
trend
Trends
Triple Negative Breast Neoplasms - epidemiology
Triple Negative Breast Neoplasms - genetics
Triple Negative Breast Neoplasms - surgery
Triple Negative Breast Neoplasms - therapy
Tumors
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!